TrumpRx Drug Prices: Every Presidential Deals Medication

Last updated 4 hours ago. Our resources are updated regularly but please keep in mind that links, programs, policies, and contact information do change.

TrumpRx lists Plavix for $15.95 beside a $771.62 list price. The site calls it a 98 percent discount. An insured patient could still pay less through a copay.

The Presidential Deals catalog displays 81 listings. Each shows a cash offer, not what every patient will pay. Compare the cash offer for the exact prescription with the insurance copay, if any, and the price of a suitable alternative.

What the advertised discount measures

KFF, the health policy research group, explains that the site’s advertised savings use the manufacturer’s wholesale list price as the reference. That list price typically does not reflect what an insured consumer would have paid. A 90 percent discount can be substantial without being a 90 percent reduction in a particular family’s spending. The percentage describes a comparison with the manufacturer’s benchmark, not with the shopper’s own best option.

A TrumpRx product page describes its amount as an out-of-pocket price and asks the visitor to select a form, strength and quantity. For Protonix, the page changes the configuration across tablet or packet form, strength and pill count. The catalog’s ‘starting at’ number is an entry point; a selected prescription can produce a different offer. A meaningful comparison uses the same drug, form, strength and amount on both sides.

TrumpRx itself warns insured visitors that their copay may be lower than the displayed cash price. KFF’s review found generic equivalents for many then-listed brands cheaper through other cash-price routes. That historical comparison does not price today’s entire catalog; it shows why the brand-name offer should not end the search. A patient should ask the pharmacist or prescriber whether an appropriate generic exists before switching a prescribed product.

The Food and Drug Administration (FDA) advises people to discuss generic medicines with a doctor, pharmacist or other health care provider. The point is a price check with clinical advice, not a recommendation to change treatment on the strength of a discount label.

Every listing in the Presidential Deals catalog

The official browse page calls this group ‘Presidential deals’ and displays 81 catalog listings. This is a publication-day snapshot, not a fixed government price schedule. The first page lists Humira Pen at $950.00 and Humira Prefilled Syringe starting at $950.00. Its fifth page shows Relenza at $52.90 against $59.00.

The final catalog page lists Insulin Lispro starting at $25.00 and displays no comparison price or discount percentage. A blank comparison field is not a zero discount; the site simply does not make that comparison on the card. Some catalog cards advertise a discount range, including the Wegovy pen and Ozempic pen on page two. Those ranges reinforce the need to open a product page and choose the actual prescription before treating any row as a quote.

Getting a deal from the screen to the pharmacy

TrumpRx functions as a search portal for discounted self-pay offers rather than a pharmacy that sells the medicines itself. For most of the medicines KFF examined, the site directed users to print a manufacturer coupon for use at a retail pharmacy. The route may look different for a drug handled through the manufacturer’s own direct-order channel. In either case, the catalog price is not a prescription or a guarantee that a pharmacy will have the product.

A valid prescription is required to buy every listed medicine. On a product page such as Protonix, visitors choose the form, strength and quantity before seeing the offer. The same page presents a coupon to show at a participating retail pharmacy. A patient should confirm both the exact product and the final checkout price before paying.

Public Citizen’s review of released agreements found that Pfizer and Eli Lilly did not write identical terms for patients in federal health programs. Eligibility for one manufacturer’s offer should not be assumed from another manufacturer’s card. Public Citizen says Pfizer’s disclosed text does not obligate it to offer covered products through its direct-to-patient platform to federal-program enrollees.

The Food and Drug Administration (FDA) describes GLP-1 receptor agonists as medicines used for type 2 diabetes or for weight loss in people with obesity or overweight. Public Citizen’s review says Lilly’s cash-price commitment for this drug class covers patients regardless of insurance status, including government insurance. Patients with Medicare or Medicaid should read the particular offer’s terms rather than assume the federal program will pay a TrumpRx transaction.

Insurance changes the comparison

KFF describes TrumpRx manufacturer coupons as self-pay transactions rather than purchases billed to private insurance. KFF says spending on such a coupon does not count toward a private plan’s deductible or out-of-pocket maximum. That difference can matter even when the cash amount is lower for a single fill. Money that counts toward a deductible can reduce what a patient owes for later covered care; a cash coupon normally does not.

Medicare’s comparison tools let a person with Medicare enter prescription drugs and estimate monthly and annual plan costs. Medicare Part D is the program’s prescription-drug coverage.

Separately, the Centers for Medicare and Medicaid Services (CMS) negotiated prices for selected Part D drugs that took effect on January 1, 2026. A Medicare negotiated price and a TrumpRx self-pay offer are different arrangements, even if a medicine appears in both conversations. The relevant choice is the patient’s actual out-of-pocket cost under the plan against the available cash route, not one headline discount against another.

KFF reports that private insurers’ negotiated prices are often lower than the wholesale list price used in TrumpRx’s percentage calculation. KFF also notes that a discounted self-pay price may help an insured person who otherwise faces a high payment before meeting a deductible. Neither observation establishes the cheaper route for a particular patient. The patient’s copay, deductible position, and any generic option have to be checked together.

What the government negotiated

The White House says President Donald Trump launched TrumpRx.gov on February 5, 2026. The administration said it had secured voluntary pricing agreements with pharmaceutical manufacturers. A Peterson-KFF Health System Tracker analysis says the manufacturers typically received tariff exemptions in exchange. Those agreements explain how the advertised brand-name offers reached a government website; they do not turn the site into an insurer.

In an August 31, 2026 fact sheet, the White House claimed patients had saved more than $700 million through TrumpRx since its launch. That is the administration’s aggregate claim, not an estimate of what any one reader can save. A Peterson-KFF comparison found TrumpRx to be the lowest among peer-country prices for five of the 32 brand-name drugs it could compare. The comparison shows both that some offers were unusually low and that the site’s broad international-price claim does not hold for every listed medicine.

Public Citizen’s review of released deal documents says Pfizer’s disclosed agreement ends on Jan. 20, 2029. The same review says the publicly released Lilly agreement redacts its termination provision. Those are limits on what can be said about the durability of the deals; they are not a known expiration date for every catalog offer. A future reader therefore needs the live offer terms, not this snapshot, to know whether a price still exists.

What the prices can prove

KFF says the site’s savings percentages compare cash offers with manufacturer wholesale list prices. KFF’s sample found cheaper generic alternatives for many of the brands then listed. A large displayed markdown proves that the cash offer is below a list benchmark; it does not prove a net saving against a covered copay or another seller. That is why the table preserves the catalog’s numbers without calling any row the lowest price for every shopper.

Public Citizen argues that redactions in the disclosed agreements obscure important prices and eligibility terms. The White House describes the deals as bringing substantial relief to patients. Both statements can be evaluated against a narrower practical question: what a given prescription costs a given patient today. The table is useful for locating offers, while a pharmacy quote and coverage details settle the personal price comparison.

Before filling the prescription

The live TrumpRx site lets a visitor search the current brand-name offers and follow the listed coupon or manufacturer route. Medicare’s own tools offer plan-cost estimates and links to pharmaceutical assistance programs for people with Medicare.

Medicare says people meeting its income and resource limits may qualify for Extra Help with drug-coverage premiums, deductibles and copays. Check the exact strength and quantity on TrumpRx. If insured, compare the immediate cash price with the copay, any suitable generic, and how a self-pay fill would affect spending over the plan year. For Medicare or Medicaid coverage, ask the plan and the offer program how that particular purchase will be handled.

For Protonix, the official page says its coupon is widely supported at retail pharmacies that dispense the drug. FDA recommends discussing generic medicines with a doctor, pharmacist or other health care provider. The choice is not between believing and disbelieving a discount; it is between actual ways to fill the same prescription safely. The catalog identifies an advertised offer; the final pharmacy quote determines what a patient will pay.